A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus
Clinical trial NCT02597049 · COMPLETED
Trial details
- NCT number
- NCT02597049
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-01
- Primary completion
- 2017-02-01
- Enrollment
- 424
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.